Lhc Group Inc (LHCG) Return on Investment ROI from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket
 


Lhc Group Inc   (NASDAQ: LHCG)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Lhc Group Inc's ROI from its fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lhc Group Inc's ROI in the fourth quarter of 2022?
Lhc Group Inc achieved a return on average invested assets (ROI) of 2.31 % in its fourth quarter of 2022, which is below Lhc Group Inc's average return on investment, which stands at 7.28%.

ROI decreased relative to the period ending Sep 30 2022, due to the decline in net income.

Within the Healthcare sector 207 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2022 from 1632 to 2365.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Investment Change TTM 23.22 % 22.43 % 25.52 % 17.92 % 6.1 %
Y / Y Net Income Change TTM -58.05 % -47.81 % -24.41 % 60.16 % 278.3 %
Investment (TTM) in Millions 2,607 2,611 2,603 2,600 2,487
Return On Investment (TTM) 2.31 % 3.24 % 3.83 % 5.51 % 6.79 %
LHCG's Overall Ranking # 2365 # 1632 # 2043 # 1787 # 1558
Seq. Investment Change TTM 1.16 % 3.41 % 7.85 % 9.21 % 0.52 %
Seq. Net Income Change TTM -27.85 % -12.43 % -25.02 % -11.46 % -10.25 %
Net Income (TTM) in Millions 60 84 95 127 144




Return On Investment LHCG's Ranking
Within: No.
Industry # 22
Sector # 208
Overall # 2365

Return On Investment Statistics
High Average Low
9.78 %
7.28 %
2.31 %
(Dec 31 2017)   (Dec 31 2022)







Financial Statements
Lhc Group Inc's IV. Quarter Investments $ 2,607 Millions LHCG's Balance sheet
Lhc Group Inc's IV. Quarter Income $ -2 Millions Quarterly LHCG's Income Statement
LHCG's Income by Division See LHCG's Income by Division


LHCG Annual Return On Investment (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Investments in Millions 2,607 2,487 1,802 1,909 1,722
Y / Y Investment Growth 4.81 % 38.01 % -5.63 % 10.85 % 149.11 %
Net Income in Millions 60 144 138 114 79
Y / Y Net Income Growth -58.05 % 4.12 % 21.15 % 44.26 % 30.7 %
Annual Return On Investment 2.31 % 5.78 % 7.65 % 5.96 % 4.58 %


Annual Roi Comment
In the fiscal year 2022 ROI decreased relative to the previous year to 2.31 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LHCG's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LHCG's Competitors
Subscribers only: Roi for Lhc Group Inc's Suppliers
Subscribers only: Return On Investment for LHCG's Customers

Other Ratios
LHCG's Roa LHCG's Inventory Turnover Ratio LHCG's Growth Rates LHCG's Dividend Statistics
LHCG's Profitability Ratios LHCG's Asset Turnover Ratio LHCG's Dividend Growth
LHCG's Roe LHCG's Valuation Ratios LHCG's Financial Strength Ratios LHCG's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2022, within Healthcare Sector ROI
Masimo Corp  6.30 %
Viemed Healthcare Inc   6.28 %
Precision Optics Corporation Inc   6.22 %
Option Care Health Inc   6.12 %
Electromed Inc   6.11 %
Acadia Healthcare Company Inc   6.06 %
Novartis Ag  5.93 %
Teleflex Incorporated  5.85 %
Universal Health Services Inc   5.85 %
Avantor Inc   5.77 %
The Oncology Institute Inc   5.74 %
Ensign Group Inc  5.66 %
Iqvia Holdings Inc   5.59 %
Addus Homecare Corp  5.51 %
Sep Acquisition Corp   5.48 %
Cryo cell International Inc   5.46 %
Supernus Pharmaceuticals inc   5.43 %
Prestige Consumer Healthcare Inc   5.40 %
U S Physical Therapy Inc  5.32 %
Medtronic Plc  5.21 %
Merit Medical Systems Inc  5.10 %
Davita Inc   5.09 %
Phibro Animal Health Corporation  5.06 %
Skinhealth Systems Inc   5.04 %
Integra Lifesciences Holdings Corp  4.94 %
Apeiron Capital Investment Corp   4.83 %
Intercure Ltd   4.80 %
Envista Holdings Corporation  4.76 %
Viatris Inc   4.61 %
Organogenesis Holdings Inc   4.43 %


Date modified: 2026-09-08T15:10:49+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.